Lynn D. Wilson

Yale University — United States

Medicine · Health Sciences

56h-index10.2kcitations269works2.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cutaneous lymphoproliferative disorders research(73), Lymphoma Diagnosis and Treatment(50), Advances in Oncology and Radiotherapy(41), Advanced Radiotherapy Techniques(36), Radiation Dose and Imaging(34)

Publications267 total

Pentostatin/TBI conditioning for allogeneic transplantation in T-cell lymphomas
Blood·2025
ASTCT and USCLC clinical practice recommendations for allogeneic stem cell transplant in mycosis fungoides and Sézary syndrome
Journal of the American Academy of Dermatology·2025· 3 cited
The caregiver burden of idiopathic inflammatory myopathies
Quality of Life Research·2025
ASTCT and USCLC Clinical Practice Recommendations for Allogeneic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome
Transplantation and Cellular Therapy·2024· 6 cited
Patient Perspectives of the Manifestations and Treatment of Anti-MDA5 Antibody–Positive Dermatomyositis: An Observational Survey
The Journal of Rheumatology·2024· 1 citedOpen Access
In Vivo Verification of Electron Paramagnetic Resonance Biodosimetry Using Patients Undergoing Radiation Therapy Treatment
International Journal of Radiation Oncology*Biology*Physics·2023· 10 cited
The personal financial burden associated with idiopathic inflammatory myopathies
Neuromuscular Disorders·2023· 4 cited
Tendon Transfers to Improve Grip and Pinch in Patients with Sporadic Inclusion Body Myositis
Plastic & Reconstructive Surgery Global Open·2023· 3 citedOpen Access
Table S5 from Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA
2023Open Access
Data from Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA
2023Open Access
Table S3 from Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA
2023Open Access
Supplementary Methods, Figures S1-6, Tables S1,2,4,6-8 from Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA
2023Open Access
Data from Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA
2023Open Access
Table S5 from Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA
2023Open Access
Supplementary Methods, Figures S1-6, Tables S1,2,4,6-8 from Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA
2023Open Access
Table S3 from Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA
2023Open Access
Factors Associated With In-Hospital Mortality in Mycosis Fungoides Patients: A Multivariable Analysis
Cureus·2022· 2 citedOpen Access
Pain profile and opioid medication use in patients with idiopathic inflammatory myopathies
Lara D. Veeken·2022· 8 citedOpen Access
Treatment of multifocal cutaneous Rosai-Dorfman disease with radiotherapy
JAAD Case Reports·2022· 5 citedOpen Access
Benefit of Deep Inspiratory Breath Hold for Right Breast Cancer When Regional Lymph Nodes Are Irradiated
Practical Radiation Oncology·2021· 25 cited
page 1 of 14Next →

Frequent Co-authors

James B. Yu(15), Roy H. Decker(12), Bruce G. Haffty(7), Barry M. Kacinski(7), Frank C. Detterbeck(6), Peter Heald(6), Benjamin D. Smith(6), Glenn Jones(5), Henry S. Park(5), Shane Lloyd(4), Richard L. Edelson(4), Anthony W. Kim(4), Charles E. Rutter(4), Brian E. Lally(3), Joseph M. Colasanto(3), Grace L. Smith(3), Charles R. Thomas(3), Christopher D. Corso(3), Irwin M. Braverman(3), Daniel Zelterman(2)